KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Revenue (2016 - 2025)

Historic Revenue for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Idexx Laboratories' Revenue rose 1329.47% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 billion, marking a year-over-year increase of 839.04%. This contributed to the annual value of $3.9 billion for FY2024, which is 646.15% up from last year.
  • Idexx Laboratories' Revenue amounted to $1.1 billion in Q3 2025, which was up 1329.47% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Revenue registered a high of $1.1 billion during Q2 2025, and its lowest value of $777.7 million during Q1 2021.
  • Moreover, its 5-year median value for Revenue was $901.6 million (2023), whereas its average is $913.4 million.
  • Its Revenue has fluctuated over the past 5 years, first surged by 2957.22% in 2021, then skyrocketed by 343.01% in 2022.
  • Idexx Laboratories' Revenue (Quarter) stood at $801.1 million in 2021, then rose by 3.43% to $828.6 million in 2022, then rose by 8.81% to $901.6 million in 2023, then grew by 5.84% to $954.3 million in 2024, then increased by 15.82% to $1.1 billion in 2025.
  • Its Revenue stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $998.4 million for Q1 2025.